ImmunityBio IBRX is moving from a U.S.-led launch to a broader international rollout. Authorizations now span the United ...
ImmunityBio IBRX enters 2026 with a commercial story that is unusually concentrated. Anktiva is the company’s first marketed ...
Abstract: In this paper, a novel pattern-diverse technique to enhance the coverage of the broadband high-gain millimeter-wave (mmW) antenna is proposed for Unmanned Aerial Vehicle (UAV) communications ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results